CANADIAN WEEKLY STOCK REPORT
BioMmune Technologies Inc. (TSXV:IMU) has fallen 3.0c (or 6.2%) to close at 45.0c. The stock fell for a second consecutive week on Friday bringing its two-week fall to 7.0c or 13.5%. Compared with the S&P/TSX 60 Index which fell 12.8 points (or 1.4%) in the two weeks, this represented a relative price change of -12.1%. The volume was 0.6 times average trading per week of 180,720 shares. In the past two weeks the market cap has slumped CAD2.6 million.
RelSci News & Alerts gets you: